BlackRock, Inc. 13D and 13G filings for Acorda Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-07-10 10:39 am Sale | 2020-06-30 | 13G | Acorda Therapeutics, Inc. ACOR | BlackRock Inc. BLK | 9,544 2.400% | -17,460 (-64.66%) | Filing |
| 2020-06-09 4:32 pm Sale | 2020-05-31 | 13G | Acorda Therapeutics, Inc. ACOR | BlackRock Inc. BLK | 27,004 6.800% | -38,322 (-58.66%) | Filing |